We are live on
!
Find out more
RCAP
Resolute Capital Asset Partners Portfolio holdings
AUM
$234M
1-Year Est. Return
136.89%
This Fund
S&P 500
This Quarter
Est. Return
+18.18%
1 Year Est. Return
+136.89%
3 Year Est. Return
+657.18%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$234M
AUM Growth
+$44M
(+23%)
Cap. Flow
+$28.1M
Cap. Flow
% of AUM
11.99%
Top 10 Holdings %
Top 10 Hldgs %
50.48%
Holding
65
New
24
Increased
9
Reduced
11
Closed
17
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
argenx
ARGX
|
+$9.9M |
| 2 |
Spotify
SPOT
|
+$8.34M |
| 3 |
Legend Biotech
LEGN
|
+$7.04M |
| 4 |
Qualcomm
QCOM
|
+$5.61M |
| 5 |
Amazon
AMZN
|
+$5.19M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$6.1M |
| 2 |
United Therapeutics
UTHR
|
+$5.93M |
| 3 |
Constellation Energy
CEG
|
+$5.58M |
| 4 |
Chevron
CVX
|
+$5.17M |
| 5 |
SCHW
Charles Schwab
SCHW
|
+$5.02M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 27.66% |
| 2 | Industrials | 15.9% |
| 3 | Consumer Discretionary | 13.9% |
| 4 | Consumer Staples | 12.31% |
| 5 | Technology | 9.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Arm
ARM
$283B
| – | – |
-28,000
| Closed | -$4.24M |
|
52
Anterix
ATEX
$1.61B
| – | – |
-51,106
| Closed | -$1.95M |
|
53
Bunge Global
BG
$23.5B
| – | – |
-15,000
| Closed | -$1.91M |
|
|
54
Constellation Energy
CEG
$101B
| – | – |
-20,000
| Closed | -$5.58M |
|
55
Carpenter Technology
CRS
$22B
| – | – |
-10,000
| Closed | -$3.94M |
|
|
56
Chevron
CVX
$420B
| – | – |
-25,000
| Closed | -$5.17M |
|
57
Dell
DELL
$361B
| – | – |
-25,000
| Closed | -$4.1M |
|
58
Grocery Outlet
GO
$1.11B
| – | – |
-50,000
| Closed | -$353K |
|
|
59
NVIDIA
NVDA
$5.27T
| – | – |
-35,000
| Closed | -$6.1M |
|
60
Quanta Services
PWR
$97.8B
| – | – |
-3,500
| Closed | -$1.92M |
|
61
Telephone and Data Systems
TDS
$4.31B
| – | – |
-70,000
| Closed | -$2.95M |
|
|
62
United Therapeutics
UTHR
$21.3B
| – | – |
-10,000
| Closed | -$5.93M |
|
|
ORKA
63
Oruka Therapeutics
ORKA
$6.12B
| – | – |
-12,500
| Closed | -$613K |
|
|
SPRB
64
Spruce Biosciences
SPRB
$154M
| – | – |
-4,000
| Closed | -$261K |
|
|
SOLS
65
Solstice Advanced Materials
SOLS
$9.77B
| – | – |
-10,000
| Closed | -$762K |
|
Similar funds
ONSWM
F4L
ACM
RCM
CI
AWA
PPA
KIG
Resolute Capital Asset Partners's Q2 2026 Portfolio in Review
As of Q2 2026, Resolute Capital Asset Partners held 65 positions worth $234M, up 23% from $190M the previous quarter. Its ten largest holdings account for 50% of the portfolio.
Resolute Capital Asset Partners deployed $28.1M of net new capital in Q2 2026, opening 24 new positions and adding to 9 existing holdings. Its largest new stake was argenx: 12,000 shares worth $11.1M.
By sector, the portfolio is most concentrated in Healthcare at 28% of assets, up from 17% a quarter earlier, followed by Industrials and Consumer Discretionary.
On the sell side, the largest reduction was Charles Schwab, an estimated $5.02M trimmed.
- Resolute Capital Asset Partners's largest Q2 2026 buy was argenx: 12,000 shares worth $11.1M.
- Resolute Capital Asset Partners added most to Amazon in Q2 2026, an estimated $5.19M increase.
- Resolute Capital Asset Partners's biggest Q2 2026 reduction was Charles Schwab, cutting an estimated $5.02M.
- Resolute Capital Asset Partners fully exited NVIDIA in Q2 2026, selling an estimated $6.1M.
- Resolute Capital Asset Partners's ten largest holdings make up 50% of its $234M portfolio in Q2 2026.
- Resolute Capital Asset Partners opened 24 new positions and closed 17 in Q2 2026.
- Resolute Capital Asset Partners's portfolio value rose 23% quarter-over-quarter to $234M.
Based on Resolute Capital Asset Partners's 13F filing for Q2 2026, filed 14 Aug 2026.